Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥935.00 JPY
Change Today +14.00 / 1.52%
Volume 46.8K
As of 2:00 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

vital ksk holdings inc (3151) Snapshot

Open
¥921.00
Previous Close
¥921.00
Day High
¥944.00
Day Low
¥919.00
52 Week High
09/26/14 - ¥999.00
52 Week Low
08/6/14 - ¥786.00
Market Cap
57.2B
Average Volume 10 Days
35.5K
EPS TTM
¥79.31
Shares Outstanding
61.2M
EX-Date
09/28/15
P/E TM
11.8x
Dividend
¥18.00
Dividend Yield
1.93%
Current Stock Chart for VITAL KSK HOLDINGS INC (3151)

Related News

No related news articles were found.

vital ksk holdings inc (3151) Related Businessweek News

No Related Businessweek News Found

vital ksk holdings inc (3151) Details

Vital KSk Holdings, Inc. engages in the wholesale and retail of pharmaceutical products in Japan. It is involved in the wholesale of veterinary drugs; and agricultural chemicals and materials, etc. The company also engages in the dispensing pharmacy, nursing care, transportation, parking, and real estate management businesses, as well as mail-order business of health-related products. In addition, it operates as insurance agent and OTC drug manufacturer; and provides medical management consulting services. Vital KSk Holdings, Inc. is headquartered in Tokyo, Japan.

3,763 Employees
Last Reported Date: 06/29/15

vital ksk holdings inc (3151) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vital ksk holdings inc (3151) Key Developments

Vital KSK Holdings Inc. Announces Consolidated and Non Consolidated Earnings Results for the Full Year Ended March 31, 2015; Provides Consolidated Earnings Guidance for the First Half and Full Year of 2016

Vital KSK Holdings Inc. announced consolidated and non consolidated earnings results for the full year ended March 31, 2015. For the period, the consolidated company reported net sales of JPY 548,012 million compared with JPY 564,655 million for the same period a year ago. Operating income was JPY 1,812 million compared with JPY 3,199 million for the same period a year ago. Ordinary income was JPY 6,125 million compared with JPY 6,632 million for the same period a year ago. Net income was JPY 4,527 million or JPY 79.51 per share compared with JPY 4,235 million or JPY 71.96 per share for the same period a year ago. Cash flows from operating activities was JPY 9,515 million compared with cash used in operating activities of JPY 10,409 million for the same period a year ago. Income before income taxes and minority interests was JPY 6,390 million compared with JPY 6,929 million for the same period a year ago. Purchase of property, plant and equipment was JPY 3,460 million compared with JPY 4,846 million for the same period a year ago. Purchase of intangible assets was JPY 898 million compared with JPY 1,081 million for the same period a year ago. For the period, the non consolidated company reported net sales of JPY 1,868 million compared with JPY 1,770 million for the same period a year ago. Operating income was JPY 1,103 million compared with JPY 1,215 million for the same period a year ago. Ordinary income was JPY 1,026 million compared with JPY 1,180 million for the same period a year ago. Net income was JPY 1,045 million or JPY 18.35 per share compared with JPY 1,150 million or JPY 19.55 per share for the same period a year ago. The company provided consolidated earnings guidance for the first half and full year of 2016. For the first half, the company expects to report net sales of JPY 281,000 million, operating income of JPY 430 million, ordinary income of JPY 2,200 million and net income of JPY 1,400 million or JPY 25.04 per share. For the full year, the company expects to report net sales of JPY 573,600 million, operating income of JPY 1,850 million, ordinary income of JPY 5,340 million and net income of JPY 3,420 million or JPY 61.16 per share.

Vital KSK Holdings Inc. Announces Yearend Dividend or the Year Ended March 31, 2015, Payable on June 8, 2015; Provides Second Quarter and Yearend Dividend Guidance for the Year Ending March 31, 2016

Vital KSK Holdings Inc. announced yearend dividend of JPY 10.00 per share for the year ended March 31, 2015 against JPY 8.00 per share a year ago, payable on June 8, 2015 For the year ending March 31, 2016, the company expects second quarter end dividend of JPY 8.00 per share. For the year ending March 31, 2016, the company expects yearend dividend of JPY 10.00 per share.

Vital KSK Holdings Inc., Annual General Meeting, Jun 26, 2015

Vital KSK Holdings Inc., Annual General Meeting, Jun 26, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3151:JP ¥935.00 JPY +14.00

3151 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3151.
View Industry Companies
 

Industry Analysis

3151

Industry Average

Valuation 3151 Industry Range
Price/Earnings 12.1x
Price/Sales 0.1x
Price/Book 0.6x
Price/Cash Flow 12.1x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITAL KSK HOLDINGS INC, please visit www.vitalksk.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.